Molsentech

Making Technology the True Power of Clinical Practice

|

Clearer. Smarter. Faster.

Detect. Decide. Defend.

Shrinking PCR technology onto advanced semiconductor chips, our next-generation Bio-FET microfluidic detection technology enables optimal clinical decisions for early diagnosis and treatment. By delivering a decentralized, zero-latency diagnostic solution to the medical frontline, we are building a next-generation smart defense network.

Smart & Advanced Precision Insights

The evolution of PCR — Biochips pushing the limits of detection. Bringing precision diagnostics into everyday life, accessible anytime, anywhere.

AI-Powered Agile Deployment

Semiconductor × AI — Enabling decentralized, real-time diagnostics. Instantly deployable to the medical frontline, building a zero-latency smart defense network.

Diagnostic Device

Ultra-Sensitive

Precise detection even at low sample concentrations.

Rapid Speed

Single-operator, results in 30 minutes.

Highly Efficient

Saves up to 50% in costs.

Scalable

High-speed mass production for flexible deployment.

Simple Operation

Intuitive and easy to master.

Core Data Performance

COVID-19 Nucleic Acid Detection Chip

  • Granted EUA by Taiwan MOHW in 2021
  • 100% Positive Agreement for Clinical Samples (Ct<35)
100%
Positive Agreement
100%
Negative Agreement
Clinical results show a sensitivity of 96.8% and specificity of 95.1%. With a biochip sensitivity reaching 3 copies/ml, it delivers precise results within 20 minutes even for asymptomatic patients with extremely low viral loads, significantly enhancing early defense.

Pet Cancer Screening Chip

  • 2025 Project Collaboration Results
  • Dedicated Pet Cancer Protein Detection Platform
  • Simultaneous 4-target detection reduces false positives
4-in-1 Multiplex Cross-Validation
Sensitivity90.9%
Specificity83.3%

Clients & Partners

Partners

Ready to Upgrade to Next-Generation Diagnostics?

Contact the Molsentech technical team to discuss collaborative projects.